Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:07 PM
Ignite Modification Date:
2025-12-24 @ 3:07 PM
NCT ID:
NCT00125892
Eligibility Criteria:
Inclusion Criteria:
* Meet criteria for primary fibromyalgia syndrome as defined by the American College of Rheumatologists
Exclusion Criteria:
* Treatment with a monoamine oxidase inhibitor within 14 days prior to Visit 2 or the potential need to take within 5 days after discontinuation from the study.
* Any patients judged by their physicians to be at serious suicidal risk.
* Have uncontrolled narrow-angle glaucoma
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00125892
Study Brief:
Protocol Section:
NCT00125892